Impact of Overlapping Risks of Type 2 Diabetes and Obesity on Coronavirus Disease Severity in the United States

Overview

Journal Sci Rep

Specialty Science

Date 2021 Sep 10

PMID 34504112

Citations 20

Authors

Wataru Ando

Takeshi Horii

Takayuki Uematsu

Hideaki Hanaki

Koichiro Atsuda

Katsuya Otori

Affiliations

Soon will be listed here.

Abstract

The impact of overlapping risk factors on coronavirus disease (COVID-19) severity is unclear. To evaluate the impact of type 2 diabetes (T2D) and obesity on COVID-19 severity, we conducted a cohort study with 28,095 anonymized COVID-19 patients using data from the COVID-19 Research Database from January 1, 2020 to November 30, 2020. The mean age was 50.8 ± 17.5 years, and 11,802 (42%) patients were male. Data on age, race, sex, T2D complications, antidiabetic medication prescription, and body mass index ≥ 30 kg/m (obesity) were analysed using Cox proportional hazard models, with hospitalization risk and critical care within 30 days of COVID-19 diagnosis as the main outcomes. The risk scores were 0-4 for age ≥ 65 years, male sex, T2D, and obesity. Among the participants, 11,294 (61.9%) had obesity, and 4445 (15.8%) had T2D. T2D, obesity, and male sex were significantly associated with COVID-19 hospitalization risk. Regarding hospitalization risk scores, compared with those for hospitalization risk score 0 and critical care risk score 0, hazard ratios [95% confidence intervals] were 19.034 [10.470-34.600] and 55.803 [12.761-244.015] (P < 0.001) (P < 0.001), respectively, for risk score 4. Complications from diabetes and obesity increased hospitalization and critical care risks for COVID-19 patients.

Citing Articles

Data linkage multiplies research insights across diverse healthcare sectors.

Eisinger-Mathason T, Leshin J, Lahoti V, Fridsma D, Mucaj V, Kho A Commun Med (Lond). 2025; 5(1):58.

PMID: 40038513 PMC: 11880312. DOI: 10.1038/s43856-025-00769-y.

Symptoms, Course, and Factors Related to Long-Term Morbidity, Including Differences between Infection Strains, in Patients with Long COVID in a Primary Care Clinic in Japan: An Observational Study.

Baba K, Kawai S, Iwase S, Ushida T, Tamura Y, Arimoto M J Clin Med. 2024; 13(17).

PMID: 39274232 PMC: 11396328. DOI: 10.3390/jcm13175019.

Potential Effects of Hyperglycemia on SARS-CoV-2 Entry Mechanisms in Pancreatic Beta Cells.

Michaels T, Essop M, Joseph D Viruses. 2024; 16(8).

PMID: 39205219 PMC: 11358987. DOI: 10.3390/v16081243.

Differential Roles of Interleukin-6 in Severe Acute Respiratory Syndrome-Coronavirus-2 Infection and Cardiometabolic Diseases.

Ren J, Wang X, Nakao T, Libby P, Shi G Cardiol Discov. 2023; 3(3):166-182.

PMID: 38152628 PMC: 10750760. DOI: 10.1097/CD9.0000000000000096.

Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study.

Jimbo M, Saito S, Uematsu T, Hanaki H, Otori K, Shibuya K BMC Public Health. 2023; 23(1):1489.

PMID: 37542210 PMC: 10401821. DOI: 10.1186/s12889-023-16401-4.

References

Patoulias D, Papadopoulos C, Katsimardou A, Toumpourleka M, Doumas M . Sodium-Glucose Cotransporter 2 Inhibitors and Major COVID-19 Outcomes: Promising Mechanisms, Conflicting Data, and Intriguing Clinical Decisions. Diabetes Ther. 2020; 11(12):3003-3005. PMC: 7556544. DOI: 10.1007/s13300-020-00942-7. View

Perez-Belmonte L, Torres-Pena J, Lopez-Carmona M, Ayala-Gutierrez M, Fuentes-Jimenez F, Jorge Huerta L . Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study. BMC Med. 2020; 18(1):359. PMC: 7666969. DOI: 10.1186/s12916-020-01832-2. View

Perkin M, Heap S, Crerar-Gilbert A, Albuquerque W, Haywood S, Avila Z . Deaths in people from Black, Asian and minority ethnic communities from both COVID-19 and non-COVID causes in the first weeks of the pandemic in London: a hospital case note review. BMJ Open. 2020; 10(10):e040638. PMC: 7569709. DOI: 10.1136/bmjopen-2020-040638. View

Kosiborod M, Berwanger O, Koch G, Martinez F, Mukhtar O, Verma S . Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes Obes Metab. 2020; 23(4):886-896. PMC: 8049025. DOI: 10.1111/dom.14296. View

Wang T, Feng X, Zhou J, Gong H, Xia S, Wei Q . Type 2 diabetes mellitus is associated with increased risks of sarcopenia and pre-sarcopenia in Chinese elderly. Sci Rep. 2016; 6:38937. PMC: 5153616. DOI: 10.1038/srep38937. View

Hamer M, Gale C, Kivimaki M, Batty G . Overweight, obesity, and risk of hospitalization for COVID-19: A community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A. 2020; 117(35):21011-21013. PMC: 7474583. DOI: 10.1073/pnas.2011086117. View

Wikner C, Gigante B, Hellenius M, de Faire U, Leander K . The risk of type 2 diabetes in men is synergistically affected by parental history of diabetes and overweight. PLoS One. 2013; 8(4):e61763. PMC: 3632519. DOI: 10.1371/journal.pone.0061763. View

Ali M, Bullard K, Saaddine J, Cowie C, Imperatore G, Gregg E . Achievement of goals in U.S. diabetes care, 1999-2010. N Engl J Med. 2013; 368(17):1613-24. DOI: 10.1056/NEJMsa1213829. View

Bossi A, Forloni F, Colombelli P . Lack of Efficacy of SGLT2-i in Severe Pneumonia Related to Novel Coronavirus (nCoV) Infection: No Little Help from Our Friends. Diabetes Ther. 2020; 11(7):1605-1606. PMC: 7244936. DOI: 10.1007/s13300-020-00844-8. View

10.

Best J, Mohan S, Kong A, Patel K, Pagel J, Ivanov B . Baseline Demographics and Clinical Characteristics Among 3471 US Patients Hospitalized with COVID-19 and Pulmonary Involvement: A Retrospective Study. Adv Ther. 2020; 37(12):4981-4995. PMC: 7548311. DOI: 10.1007/s12325-020-01510-y. View

11.

Gold J, Rossen L, Ahmad F, Sutton P, Li Z, Salvatore P . Race, Ethnicity, and Age Trends in Persons Who Died from COVID-19 - United States, May-August 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(42):1517-1521. PMC: 7583501. DOI: 10.15585/mmwr.mm6942e1. View

12.

Popkin B, Du S, Green W, Beck M, Algaith T, Herbst C . Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020; 21(11):e13128. PMC: 7461480. DOI: 10.1111/obr.13128. View

13.

Raisi-Estabragh Z, McCracken C, Bethell M, Cooper J, Cooper C, Caulfield M . Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank. J Public Health (Oxf). 2020; 42(3):451-460. PMC: 7449237. DOI: 10.1093/pubmed/fdaa095. View

14.

Lalau J, Al-Salameh A, Hadjadj S, Goronflot T, Wiernsperger N, Pichelin M . Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2020; 47(5):101216. PMC: 7832745. DOI: 10.1016/j.diabet.2020.101216. View

15.

Flegal K, Carroll M, Ogden C, Curtin L . Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010; 303(3):235-41. DOI: 10.1001/jama.2009.2014. View

16.

Lundon D, Mohamed N, Lantz A, Goltz H, Kelly B, Tewari A . Social Determinants Predict Outcomes in Data From a Multi-Ethnic Cohort of 20,899 Patients Investigated for COVID-19. Front Public Health. 2020; 8:571364. PMC: 7722480. DOI: 10.3389/fpubh.2020.571364. View

17.

Izurieta H, Graham D, Jiao Y, Hu M, Lu Y, Wu Y . Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries. J Infect Dis. 2020; 223(6):945-956. PMC: 7799044. DOI: 10.1093/infdis/jiaa767. View

18.

Liang W, Liang H, Ou L, Chen B, Chen A, Li C . Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19. JAMA Intern Med. 2020; 180(8):1081-1089. PMC: 7218676. DOI: 10.1001/jamainternmed.2020.2033. View

19.

Grasselli G, Tonetti T, Protti A, Langer T, Girardis M, Bellani G . Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020; 8(12):1201-1208. PMC: 7834127. DOI: 10.1016/S2213-2600(20)30370-2. View

20.

ODriscoll M, Ribeiro Dos Santos G, Wang L, Cummings D, Azman A, Paireau J . Age-specific mortality and immunity patterns of SARS-CoV-2. Nature. 2020; 590(7844):140-145. DOI: 10.1038/s41586-020-2918-0. View